Pharmacogenomics Technology Market Size, Share & Trends Report

Pharmacogenomics Technology Market Size, Share & Trends Analysis Report By Therapeutic Area (Oncology Neurological, Cardiovascular, Immunology Disorders), By Technology, And Segment Forecasts, 2018 - 2025

  • Report ID: GVR-1-68038-940-1
  • Number of Pages: 150
  • Format: Electronic (PDF)
  • Historical Range: 2014 - 2016
  • Industry: Healthcare

Market Segmentation

  • Pharmacogenomics Technology (Theranostics and Companion Diagnostics) Therapeutic Area Outlook (Revenue, USD Million, 2014 - 2025)
    • Oncology
      • Lung Cancer
      • Breast Cancer
      • Colorectal Cancer
      • Cervical Cancer
      • Others
    • Neurological Disorders
    • Cardiovascular Disease
    • Immunological Disorders
    • Others
  • Pharmacogenomics Technology (Theranostics and Companion Diagnostics) Technology Outlook (Revenue, USD Million, 2014 - 2025)
    • PCR
    • In-situ Hybridization
    • Immunohistochemistry
    • Sequencing
    • Others
  • Pharmacogenomics Technology (Theranostics and Companion Diagnostics) Regional Outlook (Revenue, USD Million, 2014 - 2025)
    • North America
      • North America Therapeutic Area Outlook (Revenue, USD Million, 2014 - 2025)
        • Oncology
          • Lung Cancer
          • Breast Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Others
        • Neurological Disorders
        • Cardiovascular Disease
        • Immunological Disorders
        • Others
      • North America Technology Outlook (Revenue, USD Million, 2014 - 2025)
        • PCR
        • In-situ Hybridization
        • Immunohistochemistry
        • Sequencing
        • Others
      • The U.S.
        • The U.S. Therapeutic Area Outlook (Revenue, USD Million, 2014 - 2025)
          • Oncology
            • Lung Cancer
            • Breast Cancer
            • Colorectal Cancer
            • Cervical Cancer
            • Others
          • Neurological Disorders
          • Cardiovascular Disease
          • Immunological Disorders
          • Others
        • The U.S. Technology Outlook (Revenue, USD Million, 2014 - 2025)
          • PCR
          • In-situ Hybridization
          • Immunohistochemistry
          • Sequencing
          • Others
      • Canada
        • Canada Therapeutic Area Outlook (Revenue, USD Million, 2014 - 2025)
          • Oncology
            • Lung Cancer
            • Breast Cancer
            • Colorectal Cancer
            • Cervical Cancer
            • Others
          • Neurological Disorders
          • Cardiovascular Disease
          • Immunological Disorders
          • Others
        • Canada Technology Outlook (Revenue, USD Million, 2014 - 2025)
          • PCR
          • In-situ Hybridization
          • Immunohistochemistry
          • Sequencing
          • Others
    • Europe
      • Europe Therapeutic Area Outlook (Revenue, USD Million, 2014 - 2025)
        • Oncology
          • Lung Cancer
          • Breast Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Others
        • Neurological Disorders
        • Cardiovascular Disease
        • Immunological Disorders
        • Others
      • Europe Technology Outlook (Revenue, USD Million, 2014 - 2025)
        • PCR
        • In-situ Hybridization
        • Immunohistochemistry
        • Sequencing
        • Others
      • Germany
        • Germany Therapeutic Area Outlook (Revenue, USD Million, 2014 - 2025)
          • Oncology
            • Lung Cancer
            • Breast Cancer
            • Colorectal Cancer
            • Cervical Cancer
            • Others
          • Neurological Disorders
          • Cardiovascular Disease
          • Immunological Disorders
          • Others
        • Germany Technology Outlook (Revenue, USD Million, 2014 - 2025)
          • PCR
          • In-situ Hybridization
          • Immunohistochemistry
          • Sequencing
          • Others
      • The U.K.
        • The U.K. Therapeutic Area Outlook (Revenue, USD Million, 2014 - 2025)
          • Oncology
            • Lung Cancer
            • Breast Cancer
            • Colorectal Cancer
            • Cervical Cancer
            • Others
          • Neurological Disorders
          • Cardiovascular Disease
          • Immunological Disorders
          • Others
        • The U.K. Technology Outlook (Revenue, USD Million, 2014 - 2025)
          • PCR
          • In-situ Hybridization
          • Immunohistochemistry
          • Sequencing
          • Others
    • Asia Pacific
      • Asia Pacific Therapeutic Area Outlook (Revenue, USD Million, 2014 - 2025)
        • Oncology
          • Lung Cancer
          • Breast Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Others
        • Neurological Disorders
        • Cardiovascular Disease
        • Immunological Disorders
        • Others
      • Asia Pacific Technology Outlook (Revenue, USD Million, 2014 - 2025)
        • PCR
        • In-situ Hybridization
        • Immunohistochemistry
        • Sequencing
        • Others
      • Japan
        • Japan Therapeutic Area Outlook (Revenue, USD Million, 2014 - 2025)
          • Oncology
            • Lung Cancer
            • Breast Cancer
            • Colorectal Cancer
            • Cervical Cancer
            • Others
          • Neurological Disorders
          • Cardiovascular Disease
          • Immunological Disorders
          • Others
        • Japan Technology Outlook (Revenue, USD Million, 2014 - 2025)
          • PCR
          • In-situ Hybridization
          • Immunohistochemistry
          • Sequencing
          • Others
      • China
        • China Therapeutic Area Outlook (Revenue, USD Million, 2014 - 2025)
          • Oncology
            • Lung Cancer
            • Breast Cancer
            • Colorectal Cancer
            • Cervical Cancer
            • Others
          • Neurological Disorders
          • Cardiovascular Disease
          • Immunological Disorders
          • Others
        • China Technology Outlook (Revenue, USD Million, 2014 - 2025)
          • PCR
          • In-situ Hybridization
          • Immunohistochemistry
          • Sequencing
          • Others
    • Latin America
      • Latin America Therapeutic Area Outlook (Revenue, USD Million, 2014 - 2025)
        • Oncology
          • Lung Cancer
          • Breast Cancer
          • Colorectal Cancer
          • Cervical Cancer
          • Others
        • Neurological Disorders
        • Cardiovascular Disease
        • Immunological Disorders
        • Others
      • Latin America Technology Outlook (Revenue, USD Million, 2014 - 2025)
        • PCR
        • In-situ Hybridization
        • Immunohistochemistry
        • Sequencing
        • Others
      • Brazil
        • Brazil Therapeutic Area Outlook (Revenue, USD Million, 2014 - 2025)
          • Oncology
            • Lung Cancer
            • Breast Cancer
            • Colorectal Cancer
            • Cervical Cancer
            • Others
          • Neurological Disorders
          • Cardiovascular Disease
          • Immunological Disorders
          • Others
        • Brazil Technology Outlook (Revenue, USD Million, 2014 - 2025)
          • PCR
          • In-situ Hybridization
          • Immunohistochemistry
          • Sequencing
          • Others
        • MEA
          • MEA Therapeutic Area Outlook (Revenue, USD Million, 2014 - 2025)
            • Oncology
              • Lung Cancer
              • Breast Cancer
              • Colorectal Cancer
              • Cervical Cancer
              • Others
            • Neurological Disorders
            • Cardiovascular Disease
            • Immunological Disorders
            • Others
          • MEA Technology Outlook (Revenue, USD Million, 2014 - 2025)
            • PCR
            • In-situ Hybridization
            • Immunohistochemistry
            • Sequencing
            • Others
          • South Africa
            • South Africa Therapeutic Area Outlook (Revenue, USD Million, 2014 - 2025)
              • Oncology
                • Lung Cancer
                • Breast Cancer
                • Colorectal Cancer
                • Cervical Cancer
                • Others
              • Neurological Disorders
              • Cardiovascular Disease
              • Immunological Disorders
              • Others
            • South Africa Technology Outlook (Revenue, USD Million, 2014 - 2025)
              • PCR
              • In-situ Hybridization
              • Immunohistochemistry
              • Sequencing
              • Others

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2014 to 2025
  • Market estimates and forecast for product segments up to 2025
  • Regional market size and forecast for product segments up to 2025
  • Market estimates and forecast for application segments up to 2025
  • Regional market size and forecast for application segments up to 2025
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon